Bacterial Disease Diagnostic Market 2023 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2030

The bacterial disease diagnostic market was valued at USD 3.4 billion in 2022, and a CAGR of 6.2% is expected during the forecast period. Bacterial disease diagnostics is used to identify diseases caused by bacteria like cholera, typhoid, malaria, and so on. The increasing demand for early diagnosis of these diseases is driving the growth of the market.

The increasing number of patients suffering from chronic diseases is driving the growth of the market. The increasing number of pathologies worldwide is driving the market towards new heights. The most populous countries, like China and India, have the biggest markets in the region.

Impact of Covid-19

COVID-19 brought a slowdown to the market. Due to the pandemic, patients suffering from all other bacterial and viral diseases had to suffer. Priorities of people changed during the pandemic, as they all became COVID-19-centric. People were scared of the pandemic, and the closure of hospitals and pathologies made things even worse. Disruption in the supply chain, lockdown, and social distancing made the lives of people even worse.

COVID-19 had the same symptoms as pneumonia. Persistent fever and severe headaches are the symptoms of the diseases caused by bacteria. The increasing number of patients worldwide is driving the growth in the bacterial disease diagnosis market. The post-COVID era was very crucial for the bacterial infection disease market, as people became more cautious about bacterial infections and especially about respiratory diseases like lung infection, pneumonia, and breathing problems.

 Growth Drivers

The bacterial disease diagnostic market is driven by technological advancements and an increasing number of pathology centers. The increasing number of chronic disease patients is driving the growth of the market. Rising awareness about early disease detection and continuous research and development in the fields of microbiology and biotechnology are driving the growth of the market significantly. Factors like government initiatives, the introduction of novel testing methods, and the demand for point-of-care diagnostics also contribute to the growth of the market.

Factors such as funding for research and the development of novel biomarkers contribute to the market’s expansion. Typhoid and malaria kits have increased the growth of the market. The increasing number of diagnostic centers worldwide has produced an effective and efficient result.

Increasing emissions from vehicles are directly contributing to respiratory problems and driving the growth of the market. The growing need for waste water treatment and blood-borne diseases is the reason behind the significant growth of the bacterial disease diagnostic market. The presence of key market players in Asia, the Pacific, and the North American region is driving the growth of the market significantly.

Segmentation

Type

·         Bacterial Skin Infections

·         Sexually transmitted Infections

Products

·         Consumable

·         Instruments

Technology

·         DNA Microarray

·         Immunodiagnostics

·         Isothermal Nucleic Acid amplification technology

·         Polymerase Chain Reaction

End-Users

·         Hospital

·         Labs

·         Research Centers

Regional Outlook

·         Asia Pacific

·         North America

·         Latin America

·         Europe

·         Middle East and Africa

Bacterial Disease Diagnostics Market Type Segmentation

On the basis of type, the bacterial disease diagnostic market is segmented into bacterial skin infections and sexually transmitted infections. The increasing prevalence of skin infection cases worldwide is driving the growth of the bacterial skin infection market around the world. It is the leading segment and is expected to dominate during the forecast period. Sexually transmitted infections are the other cause of bacterial infections due to unsafe sexual intimacy.

Bacterial Disease Diagnostics Market Product Segmentation

On the basis of products, the bacterial disease diagnostic market is segmented into consumables and instruments. Consumables are the leading segment, and it refers to the items like test kits, reagents, and other disposable items necessary for performing tests. Instruments encompass the equipment used to conduct diagnostics, such as PCR machines, mass spectrometers, microscopes, and automatic analyzers.

These segments collectively support the process of diagnosing bacterial infections by providing the necessary tools and materials for accurate testing and analysis. The increasing prevalence of typhoid, pneumonia, and cholera is driving the growth in the region significantly. Sexually transmitted infections and skin infection cases worldwide are driving the growth of the market significantly.

Bacterial Disease Diagnostics Market End User

On the basis of end-users, the bacterial disease diagnostic market is segmented into hospitals, labs, and research centers. Hospitals are the leading segment, with labs following it, and are expected to dominate the market during the forecast period. The increasing prevalence of bacterial diseases like typhoid, cholera, and other bacterial diseases is driving the growth of the market. Increasing facilities and efficiency in test reports by various labs in the market have driven the growth significantly. Increasing inclination towards research centers by governments worldwide is another reason behind the significant growth in the market.

Regional Outlook

On the basis of regions, the bacterial disease diagnostics market is segmented into 5 regions: Asia Pacific, North America, and Latin America. Europe, the Middle East, and Africa. North America, due to the rising instances of fatal infections due to bacterial diseases in the region, is driving the growth of the market. The United States is the region's leading segment, and it is significantly contributing to market growth. Asia-Pacific region, due to increasing cases of typhoid and other bacterial diseases, is also a major cause behind the growth in the region. Countries with a leading population, like India, in the rainy season record the highest number of patients suffering due to bacterial infection.

The increasing number of cases in rural as well as urban areas is driving the growth of the market. In Europe, the market is influenced by factors such as improving healthcare infrastructure, government initiatives supporting better diagnostic facilities, and increased awareness among healthcare professionals in countries like Italy, Germany, the United Kingdom, and Denmark. Improving economic conditions and increasing access to healthcare systems are driving market growth in the Latin American region. Demand for advanced diagnostic technologies is the need of the hour. Effective treatment options in the Middle East are driving the growth of the market.

Key Players

·         Donaher Corp.

·         Torus Biosystem

·         Bruker Corp.

·         Generi Biotech

·         Accelerate Diagnostics INC

·         Diasorin Spa

·         Becton Dickinson and Company

·         F.Hoffman La-Roche Ltd.

·         Abbott Laboratories

·         Other Players